Insulin resistance in postmenopausal women: concurrent effects of hormone replacement therapy and coffee

References

• Greendale G A, Lee N P, Arriola E R. The menopause. Lancet 1999; 353: 571–580
   PubMed Web of Science ®Google Scholar
• Stampfer M J, Colditz G A, Willet W C. Menopause and heart disease: a review. Ann NY Acad Sci 1990; 592: 192–203
   Google Scholar
• Brochier M L, Arwidson P. Coronary heart disease risk factors in women. Eur Heart J 1998; 19(Suppl A)A45–52
   PubMedGoogle Scholar
• Rosano G MC, Sarrel P M, Poole-Wilson P A, Collins P. Beneficial effect of estrogen on exercise-induced myocardial ischemia in women with coronary artery disease. Lancet 1993; 342: 133–136
   PubMed Web of Science ®Google Scholar
• Ferrer J, Neyro J L, Estevez A. Identification of risk factors for prevention and early diagnosis of asymptomatic post-menopausal women. Maturitas 2005; 52(Suppl 1)S7–22
   PubMedGoogle Scholar
• Trovato G M, Catalano D, Sciacchitano G, Zuccalà G, Iannetti E. Resistive index of renal artery and blood pressure in post menopausal women. Maturitas 2002; 41: 223–230
   PubMed Web of Science ®Google Scholar
• Carr M C. The emergency of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003; 88: 2404–2411
   PubMed Web of Science ®Google Scholar
• Mesch V R, Boero L E, Siseles N O, et al. Metabolic syndrome throughout the menopausal transition: influence of age and menopausal status. Climacteric 2006; 9: 40–48
   PubMed Web of Science ®Google Scholar
• Hollenbeck G, Reaven G M. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987; 64: 1169–1173
   PubMed Web of Science ®Google Scholar
• Laires M J, Moreira H, Monteiro C P, et al. Magnesium, insulin resistance and body composition in healthy postmenopausal women. J Am Coll Nutr 2004; 23: 510–513S
   PubMed Web of Science ®Google Scholar
• Godsland I F, Stevenson J C. Insulin resistance: syndrome or tendency?. Lancet 1995; 346: 100–103
   PubMed Web of Science ®Google Scholar
• Savage P J. Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention. Ann Intern Med 1996; 124: 123–126
   PubMed Web of Science ®Google Scholar
• Reaven G M, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334: 347–381
   Google Scholar
• Edmunds E, Lip G. Cardiovascular risk in women: the cardiologist's perspective. Q J Med 2000; 93: 135–145
   Google Scholar
• Trovato G M, Catalano D, Caruso G, et al. Relationship between cardiac function and insulin resistance in obese patients. Diabetes Nutr Metab 2001; 14: 325–328
   PubMedGoogle Scholar
• Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991; 14: 1132–1143
   PubMed Web of Science ®Google Scholar
• Nosadini R, Crepaldi G, D'Angelo A. Diabetes mellitus and hypertension: a physiologic basis for a rational therapeutic approach. Am Heart J 1991; 121: 1289–1293
   PubMed Web of Science ®Google Scholar
• El-Atat F A, Stas S N, McFarlane S I, Sowers J R. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 2004; 15: 2816–2827
   PubMed Web of Science ®Google Scholar
• Feldstein C A, Akopian M, Renauld A, Olivieri A O, Cauterucci S, Garrido D. Insulin resistance and hypertension in postmenopausal women. J Hum Hypertens 2002; 16: 145–150
   Google Scholar
• Poehlman E T, Toth M J, Gardner A W. Changes in energy balance and body composition at menopause: a longitudinal study. Ann Intern Med 1995; 123: 673–675
   PubMed Web of Science ®Google Scholar
• Shinozaki K, Suzuki M, Ikebuki M, Hara M, Harano Y. Demonstration of insulin resistance in coronary artery disease documented with angiography. Diabetes Care 1996; 19: 1–7
   PubMed Web of Science ®Google Scholar
• Sheu W, Jeng C, Young M S, Le W J, Chen Y T. Coronary artery disease risk predicted by insulin resistance, plasma lipids, and hypertension in people without diabetes. Am J Med Sci 2000; 319: 84–88
   PubMed Web of Science ®Google Scholar
• Landsberg L. Pathophysiology of obesity-related hypertension: role of insulin and SNS. J Cardiovasc Pharmacol 1994; 23: 1–8
   PubMed Web of Science ®Google Scholar
• Faria A N, Ribeiro Filho F F, Gouveia Ferreira S R, Zanella M T. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women. Obes Res 2002; 10: 1203–1206
   PubMedGoogle Scholar
• Grady D, Herrington D, Bittner V, et al. HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288: 49–57
   PubMed Web of Science ®Google Scholar
• Rossouw J E, Anderson G L, Prentice R L, et al. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Grady D, Rubin S M, Petitti D B, et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016–1037
   PubMed Web of Science ®Google Scholar
• Grodstein F, Sampfer M J, Golditz G A, et al. Postmenopausal hormone replacement therapy and mortality. N Engl J Med 1997; 336: 1769–1775
   PubMed Web of Science ®Google Scholar
• Stevenson J C, Proudler A J, Walton C, Godsland I F. HRT mechanisms of action: carbohydrates. Int J Fertil Menopausal Stud 1994; 39: 50–55
   PubMedGoogle Scholar
• Kawecka-Jaszcz K, Czarnecka D, Dembinska-Kiec A, Olszanecka A, Zdzienicka A. Insulin resistance and lipids in hypertensive women on hormone replacement therapy. Blood Press 2002; 11: 28–34
   PubMed Web of Science ®Google Scholar
• Sumino H, Ichikawa S, Itoh H, et al. Hormone replacement therapy decreases insulin resistance in Japanese postmenopausal women with impaired and normal glucose tolerance. Horm Res 2003; 60: 134–142
   PubMed Web of Science ®Google Scholar
• Mueck A O, Seeger H. Effect of hormone therapy on BP in normotensive and hypertensive postmenopausal women. Maturitas 2004; 49: 189–203
   PubMed Web of Science ®Google Scholar
• Affinito P, Palomba S, Bonifacio M, et al. Effects of hormonal replacement therapy in postmenopausal hypertensive patients. Maturitas 2001; 40: 75–83
   PubMed Web of Science ®Google Scholar
• Kalela A, Jokela H, Lehtimaki T, et al. Effect of the cessation of long-term hormone replacement therapy on plasma plasminogen activator inhibitor-1 and fibrinogen. Eur J Obstet Gynecol Reprod Biol 2006; 125: 217–220
   PubMed Web of Science ®Google Scholar
• Sites C K, L'Hommedieu G D, Toth M J, et al. The effect of hormone replacement therapy on body composition, body fat distribution, and insulin sensitivity in menopausal women: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab 2005; 90: 2701–2707
   PubMed Web of Science ®Google Scholar
• Chen Z, Bassford T, Green S B, et al. Postmenopausal hormone therapy and body composition – a substudy of the estrogen plus progestin trial of the Women's Health Initiative. Am J Clin Nutrition 2005; 82: 651–656
   PubMed Web of Science ®Google Scholar
• Van Dam R M, Willett W C, Manson J E, Hu F B. Coffee, caffeine, and risk of type 2 diabetes: a prospective cohort study in younger and middle-aged US women. Diabetes Care 2006; 29: 398–403
   PubMed Web of Science ®Google Scholar
• Pereira M A, Parker E D, Folsom A R. Coffee consumption and risk of type 2 diabetes mellitus: an 11-year prospective study of 28 812 postmenopausal women. Arch Intern Med 2006; 166: 1311–1316
   PubMed Web of Science ®Google Scholar
• Stump C S, Hamilton M T, Sowers J R. Effect of antihypertensive agents on the development of type 2 diabetes mellitus. Mayo Clin Proc 2006; 81: 796–806
   PubMed Web of Science ®Google Scholar
• , et al. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993; 153: 154–183
   PubMed Web of Science ®Google Scholar
• Matthews D R, Hosker J P, Rudenski A S, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412–419
   PubMed Web of Science ®Google Scholar
• Ohnishi H, Saitoh S, Ura N, et al. Relationship between insulin resistance and accumulation of coronary risk factors. Diabetes Obes Metab 2002; 4: 388–393
   PubMed Web of Science ®Google Scholar
• Wallace T M, Levy J C, Matthews D R. Use and abuse of HOMA modeling. Diabetes Care 2004; 27: 1487–1495
   PubMed Web of Science ®Google Scholar
• Steiner A Z, Howard N, Lobo R A, et al. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial. Menopause 2005; 12: 728–733
   PubMed Web of Science ®Google Scholar
• Rossouw J E. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease. Ann N Y Acad Sci 2006; 1089: 444–453
   PubMed Web of Science ®Google Scholar
• Amigoni S, Morelli P, Parazzini F, Chatenoud L. Determinants of elevated blood pressure in women around menopause: results from a cross-sectional study in Italy. Maturitas 1999; 34: 25–32
   Web of Science ®Google Scholar
• Furberg A S, Veierod M B, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J Natl Cancer Inst 2004; 96: 1152–1160
   PubMed Web of Science ®Google Scholar
• Bruning P F, Bonfrer J M, van Noord P A, Hart A A, de Jong-Bakker M, Nooijen W J. Insulin resistance and breast-cancer risk. Int J Cancer 1992; 52: 511–516
   PubMed Web of Science ®Google Scholar
• Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003; 289: 1799–1804
   PubMed Web of Science ®Google Scholar
• Agardh E E, Carlsson S, Ahlbom A, et al. Coffee consumption, type 2 diabetes and impaired glucose tolerance in Swedish men and women. J Intern Med 2004; 255: 645–652
   PubMed Web of Science ®Google Scholar
• Ruhl C E, Everhart J E. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005; 128: 24–32
   PubMed Web of Science ®Google Scholar
• Corrao G, Zambon A, Bagnardi V, D'Amicis A, Klatsky A. Collaborative SIDECIR Group. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol 2001; 11: 458–465
   PubMed Web of Science ®Google Scholar
• Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis and the metabolic syndrome. Hepatology 2003; 37: 917–923
   PubMed Web of Science ®Google Scholar
• Clark J M. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006; 40(Suppl 1)S5–10
   PubMed Web of Science ®Google Scholar
• Lofgren I E, Herron K L, West K L, et al. Weight loss favorably modifies anthropometrics and reverses the metabolic syndrome in premenopausal women. J Am Coll Nutr 2005; 24: 486–493
   PubMed Web of Science ®Google Scholar
• Seelig M S, Altura B M, Altura B T. Benefits and risks of sex hormone replacement in postmenopausal women. J Am Coll Nutr 2004; 23: 482–496S
   PubMed Web of Science ®Google Scholar
• Ilich J Z, Brownbill R A, Tamborini L, Crncevic-Orlic Z. To drink or not to drink: how are alcohol, caffeine and past smoking related to bone mineral density in elderly women. J Am Coll Nutr 2002; 21: 536–544
   PubMed Web of Science ®Google Scholar